USP22 and inflammatory bowel disease: In agreement with our in vivo observations, gene set enrichment analysis (GSEA) [18,19] revealed that USP22 depletion resulted in increased expression of genes upregulated in inflamed tissue in DSS-treated mice [20] as well as in patients with IBD [21,22] (Figure 5A).